A new North American study has found a single supervised dose of LSD can dramatically ease anxiety symptoms — and even put some patients into remission — without the need for ongoing therapy.

Researchers tested a pharmaceutical version of the psychedelic drug, called MM120, on 198 adults with generalized anxiety disorder.

“This is a chronic, impairing condition that affects about 10 per cent of the global population,” said Dr. Maurizio Fava, chair of psychiatry at the Mass General Brigham Academic Medical Centre in Boston.

After 12 weeks, Fava says 65 per cent of people who got a single 100-milligram dose said their symptoms improved dramatically.

Also read: • YVR introduces therapy ponies • Vancouver clinic aims to treat depression with ketamine and meditation

“If you can actuall

See Full Page